Skip to content

Public FDA record

Z-1504-06: Therakos Photopheresis Procedural Kit for use with the UVAR XTS Instrument. (catalog number XT125)

Recall record Z-1504-06 for Therakos Inc. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1504-06
Company in FDA record
Therakos Inc
FDA classification date
Sep 14, 2006
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 20, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

Centrifuge Bowl may leak

Source facts

Action
The recalling firm sent a recall letter dated 7/18/06 to their customers informing them of the problem. The letter gave instructions for continued use until new kits are available.
Initiated
2006-07-18
Root cause
Other
Terminated
2007-06-19
Distribution
Nationwide (including AL, AR, AZ, CA, CO, FL, GA, IL, MA, MD, MI, MO, NE, NJ, NY, OK, OR, PA, TN, TX, UT, VA, WA, and WI). Worldwide, including France, Cyprus, Hungary, Saudi Arabia, Singapore, United Kingdom, Austria, Germany, Norway, Italy, Turkey and Portugal.
Recall number
Z-1504-06
Recall status
Terminated
CDRH record ID
47108
FDA classified
2006-09-14
Recall event number
35894

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗